Literature DB >> 15474485

Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-terminal IGFBP-2 fragment in vivo.

A Hoeflich1, R Reisinger, B S Schuett, M W Elmlinger, V C Russo, G A Vargas, P M Jehle, H Lahm, I Renner-Müller, E Wolf.   

Abstract

Insulin-like growth factor binding protein-2 (IGFBP-2) as one of the most important IGFBPs has never been assessed in the intracellular compartment in vivo. Since there is evidence for novel intracellular functions of distinct IGFBPs, we investigated the presence of IGFBP-2 inside the cell. In peri/nuclear fractions of various tissues isolated from IGFBP-2 transgenic and non-transgenic mice we were able to show the presence of intact IGFBP-2. In addition, we demonstrate the presence of a highly conserved carboxyl-terminal IGFBP-2 fragment in the peri/nuclear fraction by using different peptide-induced antibodies. In pancreatic sections, confocal microscopy revealed the presence of IGFBP-2 on the nuclear surface but not within the nucleus. Our findings suggest novel functions of intact IGFBP-2 and IGFBP-2 fragments within the cell.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474485     DOI: 10.1016/j.bbrc.2004.09.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway.

Authors:  Konstantin I Piatkov; Jang-Hyun Oh; Yuan Liu; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

2.  Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition.

Authors:  Xavier Terrien; Elise Bonvin; Sophie Corroyer; Olivier Tabary; Annick Clement; Alexandra Henrion Caude
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

3.  Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling.

Authors:  Adda Grimberg; Carrie M Coleman; Zonggao Shi; Timothy F Burns; Timothy K MacLachlan; Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2006-10-30       Impact factor: 4.742

4.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

5.  Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.

Authors:  Zonggao Shi; Maria J Henwood; Peter Bannerman; Dalia Batista; Anelia Horvath; Marta Guttenberg; Constantine A Stratakis; Adda Grimberg
Journal:  Growth Horm IGF Res       Date:  2007-02-05       Impact factor: 2.372

6.  PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions.

Authors:  Kenichi Miyako; Laura J Cobb; Malik Francis; Alden Huang; Bonnie Peng; John E Pintar; Hiroyoshi Ariga; Pinchas Cohen
Journal:  Mol Endocrinol       Date:  2008-12-18

7.  Structural and functional analysis of the amphioxus IGFBP gene uncovers ancient origin of IGF-independent functions.

Authors:  Jianfeng Zhou; Jianhai Xiang; Shicui Zhang; Cunming Duan
Journal:  Endocrinology       Date:  2013-07-11       Impact factor: 4.736

Review 8.  IGFBP2: integrative hub of developmental and oncogenic signaling network.

Authors:  Tao Li; M Elizabeth Forbes; Gregory N Fuller; Jiabo Li; Xuejun Yang; Wei Zhang
Journal:  Oncogene       Date:  2020-01-10       Impact factor: 9.867

9.  Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer.

Authors:  Ying Zhang; Xia Ying; Suxia Han; Jing Wang; Xia Zhou; E Bai; Jianying Zhang; Qing Zhu
Journal:  Int J Oncol       Date:  2012-11-15       Impact factor: 5.650

10.  IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Authors:  C Y Chua; Y Liu; K J Granberg; L Hu; H Haapasalo; M J Annala; D E Cogdell; M Verploegen; L M Moore; G N Fuller; M Nykter; W K Cavenee; W Zhang
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.